Target intelligence / Profile preview

DNA methyltransferase 1-associated protein 1 (DMAP1)

Target
DMAP1
Molecular classification
Chromatin-associated protein, Epigenetic regulator, Histone modification complex subunit (component of nucleosome acetyltransferase of H4 complex or NuA4 HAT complex)
01

Overview

DNA methyltransferase 1-associated protein 1 (DMAP1) is a chromatin-associated regulatory protein encoded by the DMAP1 gene in humans. DMAP1 acts as a subunit of various protein complexes involved in the repression and activation of transcription, frequently through its interaction with DNA methyltransferase 1 (DNMT1) during DNA replication. By engaging with DNMT1, histone deacetylase 2, and other chromatin regulators, DMAP1 can modulate DNA methylation, histone acetylation, and heterochromatin formation, thereby influencing the maintenance of epigenetic states and proper cell cycle progression. DMAP1 is also a key member of the nucleosome acetyltransferase of H4 (NuA4) complex, which plays important roles in transcriptional activation and DNA repair. Dysregulation of DMAP1-related pathways is associated with oncogenesis and other diseases due to epigenetic silencing or activation of specific genome regions.

Other names
KIAA1425DNMAP1DNMTAP1EAF2MEAF2SWC4FLJ11543
02

Mechanism of action

Not applicable; since DMAP1 is not a primary drug target, no mechanisms of action for drugs are defined for DMAP1. Its modulatory or co-factor activity could, however, affect epigenetic drugs targeting partners such as DNMT1 or HDACs via indirect modulation.

03

Biological functions

Transcriptional repression and activation (context-dependent)Maintenance of DNA methylation patterns through interaction with DNMT1Chromatin remodelingRegulation of cell cycle progression (notably S-phase)Histone acetylation and deacetylationDNA repair assistance (direct or through chromatin modification)
04

Disease associations

Cancer (association with epigenetic regulation and potential tumor suppressor gene silencing)Neurological disorders (linked to cerebellar ataxia, deafness, and narcolepsy in context of associated gene pathways)Other (broad roles in chromatin regulatory dysfunction may impact cell proliferation and apoptosis)
05

Safety considerations

potential concerns for targeting such a protein would center on global effects on gene regulation, chromatin remodeling, and cell viability

Beyond the preview

Go deeper on DNA methyltransferase 1-associated protein 1 (DMAP1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on DNA methyltransferase 1-associated protein 1 (DMAP1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call